A membrane glycoprotein, Sec12p, required for protein transport from the endoplasmic reticulum to the Golgi apparatus in yeast by unknown
A Membrane Glycoprotein, Secl2p, Required for 
Protein Transport from the Endoplasmic Reticulum 
to the Golgi Apparatus in Yeast 
Akihiko Nakano, Daniela Brada, and Randy Schekman 
Department of  Biochemistry, University of  California, Berkeley, California 94720 
Abstract.  SECI2, a gene that is required for secretory, 
membrane,  and vacuolar proteins to be transported 
from the endoplasmic reticulum to the Golgi appara- 
tus,  has been cloned from a genomic library by com- 
plementation of a secl2 ts mutation.  Genetic analysis 
has  shown that the cloned gene integrates  at the SEC12 
locus and that a null mutation at the locus is lethal. 
The DNA sequence predicts a protein of 471  amino 
acids containing a hydrophobic stretch of 19 amino 
acids near the COOH terminus.  To characterize the 
gene product (Secl2p) in detail, a  lacZ-SECI2 gene fu- 
sion has been constructed and a polyclonal antibody 
raised against the hybrid protein.  The antibody recog- 
nizes Secl2p as a  ~70-kD protein that sediments in a 
mixed membrane fraction that includes endoplasmic 
reticulum.  Secl2p is not removed from the membrane 
fraction by treatment at high pH and high salt and  is 
not degraded by exogenous protease unless detergent is 
present.  Glycosylation of Secl2p during biogenesis is 
indicated by an electrophoretic mobility shift of the 
protein that  is influenced by tunicamycin and by impo- 
sition of an independent secretory pathway block. We 
suggest that Secl2p is an integral  membrane glycopro- 
tein with a prominent domain that faces the cytoplasm 
where it functions to promote protein transport to the 
Golgi apparatus.  In the process of transport,  Secl2p it- 
self may migrate to the Golgi apparatus and function 
in subsequent transport events. 
eries of temperature-sensitive  secretory mutants  has 
been  isolated  from  Saccharomyces cerevisiae and 
complementation  analyses  have shown that at least 
27 genes are involved in the yeast secretory pathway (9,  14, 
28, 31). Biochemical and morphological analyses of these sec 
mutants  have revealed that the process of protein  export in 
yeast can be dissected into several steps:  protein  transloca- 
tion through  the membrane of the endoplasmic reticulum 
(ER), ~  folding and posttranslational  modification  in the ER, 
transport from the ER to the Golgi apparatus,  transit through 
the Golgi apparatus to form secretory vesicles, and discharge 
of the contents of secretory vesicles at the plasma membrane 
(36). Among these steps, the movement of proteins from the 
ER to the Golgi apparatus  constitutes  the first step of trans- 
port from a membrane-bound organelle.  Protein sorting and 
packaging events that occur at this stage may use mechanisms 
that  are repeated in later  steps of membrane-to-membrane 
protein  traffic. 
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1.  Abbreviations  used  in  this  paper:  CPY,  carboxypeptidase  Y;  DPAP, 
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The ER-to-Golgi transfer process requires  t>10 genes (31). 
SEC12 is one of these  10; a temperature-sensitive  mutant, 
secl2, fails to transport secretory,  membrane,  and vacuolar 
proteins  from the ER to the Golgi apparatus  at a restrictive 
temperature (29, 31, 40). To understand  the function  of the 
SECI2 gene,  we have characterized  its product, Secl2p, by 
the application  of molecular cloning  techniques.  We report 
that Secl2p is an integral membrane glycoprotein that resides 
in the ER and Golgi membranes. 
Materials and Methods 
Strains,  Plasmids, and Materials 
The bacterial  and yeast strains used  in this study are listed in Table I. 
Escherichia  coil plasmids pUC18 (42) and pUR290 (32);  E.  coil-yeast 
shuttle plasmids YEpl3 (5), pSEY8, and pSEYC58 (11); and yeast integra- 
tion vector  YIp5  (4) have been described previously.  The yeast genomic 
DNA library originally constructed by Nasmyth and Tatchell (27) contains 
DNA fragments of a Sau 3A partial digest inserted  into the Bam HI site of 
YEpI3. 
YPD  medium contained  1%  Bacto-Yeast Extract,  2%  Bacto-Peptone 
(both from Difco Laboratories, Inc., Detroit, M1), and 5% glucose.  Mini- 
mal medium (41) was also used  with 5% glucose. 
All  reagents  used  were  of  analytical grade.  [et-32P]dCTP, H235SO4, 
[a-35S]dCTP, and Na~'-5I were obtained from Amersham Corp.  (Arlington 
Heights,  IL).  Nitrocellulose  filters were from Schleicher & Schuell,  Inc. 
(Keene, NH), and nylon membranes were from Sartorius Filters Inc. (Hay- 
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Strain  Genotype  Source or reference 
S.  cerevisiae 
X2180-1B  Mata gal2  YGSC* 
MBYI0-7A  Mata sec12-4 ura3-52 leu2-3,112 trpl-289 his suc  M.  Bernstein~: 
MBY10-7C  Matot sec12-4 ura3-52 1eu2-3,112 trpl-289 his suc  M.  Bernstein~: 
MBYI2-6D  Mata secl8-1  ura3-52 leu2-3,112 trpl-289 his  M.  Bernstein* 
SF821-8A  Mata secT-1 ura3-52 leu2-3,112 trpl-289 his4-580  ~  R.  Schekman and C.  Field:~ 
ANY1-7D  Mata ura3-52 1eu2-3,112  This study 
TAY69  Mata/Mata ura3-52/ura3-52 leu2-3,112/leu2-3,112  T.  Achstetter~; 
suc2-A 9/suc2-A 9 HIS4/his4-519 ADE2 /ade2-1 
E.  coli 
MC 1061  F- araD139 A (araABOIC-leu) 7679 Alacx74 galU galK rpsL hsdR  Reference 8 
BMH71-18  A (lac pro) 1  ~  laclqZ AM15 pro  +  Reference 26 
* Yeast Genetics Stock Center, University  of California,  Berkeley,  CA. 
Department  of Biochemistry,  University  of California,  Berkeley,  CA. 
ward, CA). Lyticase was prepared as described before (37). Protein A was 
labeled with  t25I by  the chloramine T  method (17).  Endoglycosidase H 
(endo H) was a gift from P. Robbins (Biology Department, Massachusetts 
Institute of Technology,  Cambridge, MA) and used as described before (40). 
Cloning and Sequence Analysis of  SEC12 
DNA clones that complement a secl2 ts mutation were isolated as described 
previously (2).  Briefly, a yeast secl2-4 strain, MBYI0-7C, was transformed 
with a genomic DNA library in YEpl3 which contains the LEU2 gene as 
a selectable marker (27). Transformants were selected on leucine-free mini- 
mal medium at 24°C for 24 h, followed by incubation at 37°C (secl2 restric- 
tive growth temperature). Growing colonies were chosen and plasmid DNA 
was isolated. Yeast plasmid DNA was propagated in E. coli strain MCI061 
and purified. Each plasmid was confirmed for secl2 complementation and 
leucine auxotrophy in the original yeast host. Two distinct clones were ob- 
tained and named pSEC1210 and pSEC1230; the latter proved to contain the 
authentic SEC12 gene (Fig.  1; also see Results). 
DNA manipulations including restriction endonuclease digestions, liga- 
tions, plasmid isolation, and E. coli transformation were carried out by the 
standard methods (suppliers' protocols; see also reference 25). Yeast trans- 
formation was achieved either by the spheroplast (38)  or lithium acetate 
method (18).  DNA nucleotide sequences were determined by the dideoxy 
method (34) in combination with deletion techniques using exonuclease III 
(Bethesda Research Laboratories, Gaithersburg, MD) or nuclease BAL 31 
(International Biotechnologies, Inc., New Haven, CT). 
Northern Blotting Analysis 
The 0.7-kb Bam HI-Sal I fragment from pSEC1230 (Fig.  1, fragment D) 
was subcloned into pUCI8 and the 4.0-kb Xho l-Hind III fragment (Fig. 
1, fragment B) into Ylp5. These recombinant plasmids were nick translated 
in  the presence of [ct-32p]dCTP  (25)  and  used as hybridization probes. 
Poly(A)÷RNA purified from yeast strain X2180-1B was electrophoresed in 
an agarose gel containing 2.2 M formaldehyde. Transfer of RNA to nitrocel- 
lulose and DNA-RNA hybridization was performed as described (25). 
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Figure 1. Restriction map of the 6.4-kb insert in plasmid pSECI230, 
which contains the authentic SEC12 gene. The heavy arrow indi- 
cates the coding region of $EC12 and its direction of transcription. 
Fragments A-D were subcloned into different vectors as described 
in the text. 
Sec12p Antiserum 
The Barn HI-Hind III fragment from pSEC1230 was inserted into pUR290 
to make an in-frame gene fusion of lacZ and SEC12. The resultant plasmid, 
pANF1 (see Fig. 4 a), was introduced into E. coli strain BMH71-18 and the 
transformant was induced to express a  lacZ-SEC12  fusion gene product 
(,'-,160 kD).  This  hybrid  protein was purified by  a  modification of the 
method of Bernstein et al. (2). BMH71-18/pANF1  was grown in  1 liter of 
Luria broth/amp medium at  37°C to an OD550 of 0.7 and isopropylthio- 
13-D-galactoside was added to 1 mM. After a  l-h incubation at 37°C, cells 
were harvested and treated with 0.2 mg/ml lysozyme. Spheroplasts were 
broken by freeze-thawing and subjected to a brief sonication. Phenylmethyl- 
sulfonyl fluoride was added to a final  concentration of 1 mM. The lysate 
(10 ml) was centrifuged for 1 h at  100,000 g in a rotor (type 40; Beckman 
Instruments, Inc., Fullerton, CA) at 4°C.  The pellet was resuspended in 
5 ml of 0.02%  SDS and again centrifuged. About 70%  of total  13-galac- 
tosidase activity was recovered in the final pellet fraction. This final pellet 
was solubilized with 3 ml of SDS gel sampling buffer in a boiling water bath 
and subjected to preparative SDS-PAGE. The hybrid protein band was cut 
out and the protein eluted from the gel electrophoretically. Eluted protein 
was e:~tensively dialyzed against distilled water and lyophilized. 
The purified hybrid protein was suspended in PBS (20 mM sodium phos- 
phate, pH 7.4,  and  150 mM NaCI) and used for immunizing rabbits. Pri- 
mary injections contained ,'~100 I.tg  of  the protein in complete Freund's adju- 
vant.  Boosts of ~50  I-tg in  incomplete Freund's adjuvant were given at 
7-10-d  intervals. The maximal titer was obtained after eight boosts. 
Subcellular Fractionation 
Wild-type yeast strain ANYI-7D harboring the SECI2 multicopy plasmid 
(pANY1-9; pSEY8 containing Xho I-Xba I fragment from pSECI230) was 
grown to 1 OI)60o in 500 ml minimal medium and centrifuged. Cells were 
treated with  10 ml of 0.1  M Tris-HCI, pH 9.4, and  10 mM dithiothreitol 
at 30°C for 20 min, sedimented, and resuspended in 10 ml YPD medium 
containing 0.5% glucose and 0.7 M sorbitol. Lyticase (6,000 U) was added 
and incubation continued for 45 rain. Spheroplasts were collected by cen- 
trifugation through a 20-ml cushion of 1.2 M sorbitol, resuspended in  10 
ml lysis buffer (0.3 M mannitol, 0.1 M KC[, 50 mM Tris-HCI, pH 7.4, and 
I mM EGTA), and immediately homogenized with a motor-driven Teflon 
pestle five times for l  min with I-min intervals on ice. The extent of lysis 
was monitored visually in a phase-contrast microscope. As an indicator of 
membrane aggregation, the latency of NADPH cytochrome c reductase to 
its substrate, cytochrome c. was examined routinely by assaying reductase 
activity in the presence and absence of 0.1% Triton X-100 (13).  Less than 
3% of the total activity was latent in each experiment, indicating that the 
cytoplasmic surface of the ER membrane was almost completely accessible 
to exogenous cytochrome c. Membrane fractions were separated by differen- 
tial centrifugation. First, the homogenate was centrifuged at 1,000 g for 10 
min in a  rotor (model SS-34; Sorvall  Instruments Div., Newton, CT) to 
yield low-speed pellet (LSP) and low-speed supernatant (LSS) fractions. 
The LSS fraction was further centrifuged at 100,000 g for 1 h in a type 40 
rotor (Beckman Instruments, Inc.) to give a high-speed pellet (HSP) and a 
high-speed supernatant (HSS). 
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NADPH cytochrome c reductase was assayed as an ER marker enzyme as 
described by  Kubota  et  al.  (21).  Heat-stable and  heat-labile dipeptidyl 
amino-peptidases (DPAPs) were assayed as Golgi and vacuole markers, 
respectively (3, 20). The cytoplasmic form of invertase and carboxypepti- 
dase Y (CPY; mature form, vacuolar) were quantified by immunoblotting. 
Immunoblotting and lmmunoprecipitation 
Crude cell extracts or subcellular fractions subjected to SDS gel electropho- 
resis were transferred to nitrocellulose filters (6), which were briefly stained 
with Ponceau S and incubated in Tris-buffered saline (50 mM Tris-HCI, pH 
7.4,  and i50 mM NaC1) containing 0.1%  NP-40 and  1%  nonfat dry milk 
for 1 h. Antibody incubations were performed in the same buffer for 3 h 
at room temperature. Filters were washed three times with the buffer for 15 
min each, treated with ~25I-protein A (5  x  104 cpm/ml, 1  x  107 cpm/gg 
protein) for 1 h at 22°C, washed again three times, and autoradiographed. 
For immunoprecipitation of Secl2p, cells were grown to an OD600 of 
0.5-1.5  in minimal medium containing  100  gM  (NH4)2SO4. Aliquots (2 
ODt00) were harvested and resuspended in 1 ml of minimal medium con- 
raining 5  IxM (NH4)2SO4. H235SO4 (0.5  mCi) was added and incubation 
continued for 1 h  at 30°C.  To  inhibit N-linked glycosylation,  10  Ixg/ml 
tunicamycin (Sigma Chemical Co., St. Louis, MO) was added 15 min be- 
fore the start of labeling. Labeled cells were chilled on ice, washed with 
10 mM NaN3  in PBS, and resuspended in 200 ~tl of PBS containing 1% 
SDS and  1 mM phenylmethylsulfonyl fluoride. Glass beads (0.2  g) were 
added and suspensions were vortexed for 2 min followed by heating in boil- 
ing water for 5 min. Extracts were adjusted to 1 ml by addition of 2% Triton 
X-100 in PBS and clarified by centrifugation for 2 min in a microcentrifuge 
(Fisher Scientific Co., Pittsburgh, PA).  Aliquots (0.5 ml) were incubated 
with  10  ltl anti-Secl2p antiserum on ice overnight and then with 5  gl 
(packed swollen volume) of Protein A-Sepharose CL-4B (Pharmacia Fine 
Chemicals, Piscataway,  NJ) with gentle agitation at room temperature for 
2 h. Sepharose bead-immune complexes were washed twice with PBS con- 
raining  1%  Triton X-100  and 0.1%  SDS and once with PBS alone,  lm- 
munoprecipitates suspended in SDS gel sample buffer were eluted from the 
beads by heating in boiling water and applied to SDS gels containing 7.5 % 
polyacrylamide.  After electrophoresis, gels  were  treated  with  Amplify 
(Amersham Corp.) and fluorographed. 
In pulse-chase experiments, cells (20Dt00)  were preincubated for 15 
min in  1 ml of minimal medium containing no sulfate, then labeled with 
2  mCi  H235SOa for  5  min.  Chase was  performed by  adding  100  mM 
(NH4hSO4,  25  mM cysteine, and 27  mM methionine. Aliquots (180  lad 
were taken at appropriate time points. Extracts were prepared as described 
above. 
Electron Microscopy 
Preparation of thin sections of yeast cells and the details of the protein 
A-gold method used for yeast will  be described elsewhere (Brada and 
Schekman, 1988). Briefly, a see7 strain harboring the SECI2 multicopy plas- 
mid (SF821-8A/pANY1-9)  was fixed twice with a  solution containing 2 % 
formaldehyde and 0.1% glutaraldehyde in 0.1  M cacodylate-HCl, pH 6.8, 
1.5 mM CaCI2, and 2.5 mM MgCI2 at 20°C for 30 min each. Fixed cells 
were embedded in 2 % low-melting-point  agarose and dehydrated in ethanol. 
Dehydrated agarose gel blocks were embedded in Lowicryl K4M resin, 
which was then polymerized by UV irradiation at -35 °C. Ultrathin sections 
were prepared and subjected to immune labeling. Sections on a grid were 
preincubated with 1% BSA in PBS for 5 min. The grid was then incubated 
with 10-fold concentrated anti-Secl2p antibody for 2 h, washed twice with 
PBS, incubated with protein A-gold suspension (8-nm particles) in 1% Tri- 
ton X-100 in PBS at an OD525 of 0.13 for 45 min, and washed again with 
PBS, 1% Triton X-100 in PBS, PBS, and water. Sections were stained with 
uranyl acetate and lead citrate and examined under an electron microscope. 
In a competition experiment, 0.1 mg/ml purified lacZ-SEC12 hybrid protein 
was included in the incubation with anti-Secl2p antibody. 
Results 
Cloning and Genetic Analysis of the Secl2 Gene 
Yeast genomic DNA clones that complement the ts mutation 
secl2-4 were isolated from a DNA library constructed on the 
multicopy  vector  YEpl3.  Among  15,0000  Leu  ÷ transfor- 
mants,  20 showed a  Ts  ÷ phenotype. Analysis of plasmids 
purified from these Ts  + transformants revealed that two dis- 
tinct fragments of DNA could complement sec12-4. Repre- 
sentative clones containing each type of insert were named 
pSEC1210 and pSEC1230.  Southern hybridization probing 
of one clone to the other showed no homology between the 
two inserts (data not shown). Smaller fragments from the in- 
serts were subcloned into a multicopy plasmid, pSEY8, or 
a single-copy centromere plasmid, pSEYC58, and the com- 
plementation ofsecl2-4 was examined. Every fragment from 
pSEC1230 that complemented secl2-4 on a multicopy plas- 
mid did so on a single-copy plasmid as well. On the other 
hand, the smallest fragment from pSEC1210 that conferred 
a Ts  + phenotype to sec12-4 on a multicopy plasmid failed to 
give Ts  + transformants on a single-copy plasmid. Therefore, 
we tentatively assumed that pSEC1230 contained the SEC12 
gene itself, whereas pSEC1210 contained a gene that could 
suppress  the sec12-4 mutation  when  its  gene dosage was 
elevated. 
A restriction map of the insert of pSEC1230 is shown in Fig. 
1. The Xho I-Xba I fragment (Fig.  1, fragment A) was the 
smallest piece of DNA that complemented secl2-4, either on 
the single-copy plasmid pSEYC58 or on the multicopy plas- 
mid pSEY8. Any further deletion of this fragment to the Bam 
HI, Kpn I, or Sal I sites resulted in a failure to complement, 
indicating that these sites were internal to the functional re- 
gion of complementing activity. To show that this activity 
was due to the SEC12 gene, chromosomal mapping of the 
cloned fragment was done.  The Xho I-Hind III fragment 
(Fig. 1, fragment B) was subcloned into the integration vec- 
tor YIp5, which harbors the URA3 gene as a marker. The 
recombinant plasmid was linearized by Bam HI digestion to 
facilitate homologous recombination and introduced into a 
secl2-4 strain, MBY10-7A. A representative Ura+/Ts ÷ trans- 
formant was  mated  with a  SEC12-URA3 strain to form a 
diploid, which was then sporulated and subjected to tetrad 
analysis. Among 37 asci analyzed, 35 showed 4:0 segrega- 
tion of the Ts+/Ts  -  phenotypes and two showed a  3:1  pat- 
tern. The Ura÷/Ura  -  phenotype segregated ~3:1.  This ex- 
periment demonstrated that the cloned DNA was integrated 
at or very close to the sec12 locus, supporting the assumption 
that pSEC1230 contained the SEC12 gene. 
The Xho I-Sal I fragment (Fig. 1, fragment C) on a cen- 
tromere plasmid, which itself did not complement sec12-4, 
was capable of converting the ts allele at a much higher fre- 
quency than by spontaneous reversion. Plasmid pSEYC58, 
with or without fragment C as an insert, was introduced into 
MBY10-7A. Several transformants were picked and grown in 
liquid culture to promote recombination between the plasmid 
and chromosomes. Cells were plated and the appearance of 
Ts  ÷ colonies was examined. The plasmid with fragment C 
conferred a  Ts  ÷ phenotype at a  frequency of 1.5  x  10  -6, 
whereas the vector alone gave no Ts  ÷ transformants out of 4 
x  107  cells.  This observation suggested that  fragment C 
contained the site of the sec12-4 mutation. Thus, from two 
lines of evidence, we confirmed that clone pSEC1230 con- 
tained the authentic SEC12 gene. 
The plasmid pSEC1210 allowed growth of sec12-4 at the 
restrictive temperature by a different mechanism.  This ap- 
parent complementation may result from overproduction of 
another protein that suppresses the effect  of  the secl2-4 muta- 
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ACTGCGTCTGGTCTAATTTCTC -175 
AAAGCTAGTTATTAT•TTTATCTTGAATGGTGATGACAATAGAGTAAGAATGAGGGAAAAAAGAAAAGTTGAAAAAAAAAAAATCCA  -88 
AAAAATTCAAAAACGTGTACAGAAACCTAGAAGGATACGTGATAGAAATACAG~A~-~CAAGGTTGAGATACAATCGAGCCACT  -I 
1 
ATG AAG TTC GTG ACA GCT AGT TAT 
Met Lys Phe Val Thr Ala Set Tyr 
GAC ACA TTA CTT GTG GCA GG~ GGT 
Asp Thr Leu Leu Val Ala Gly Gly 
BamHI 
TTG CGC GT~-G~r'~T  ACC AAA GAT 
Leu Arg Val Asp Pro Thr Lys Asp 
GAA GAC AAC GAC GAC TCT CCT ACT 
Glu Asp Asn Asp Asp Set Pro Thr 
GAA AAT AGC ACT AAG ATT ACC CAA 
Glu Ash Set Thr Lys  Ile Thr Gln 
GTG AAT GAT CAA TTG GAG TTC CTC 
Val Asn Asp Gln Leu Glu Phe Leu 
ACG AAG CTG GTT TAT ATT TCA CGA 
Thr Lys  Leu Val Tyr  Ile Ser Arg 
ATA ATG AGA ATC ATT GAC CCG AGC 
Ile Met Arg Ile Ile Asp Pro Set 
AAG GAT TTA CAC TTT TCC ACT GAT 
Lys Asp Leu His Phe Set Thr Asp 
ATT TCA ACA GTG ACT GGA AGT TGC 
Ile Set Thr Val Thr Gly Ser Cys 
AAA ATA AAC TTC ATA GCC GAT GAC 
Lys  Ile Ash Phe Ile Ala Asp Asp 
GTG CTG ACC AAA ATA AGC ATC AAA 
Val Leu Thr Lys  Ile Set  lle Lys 
AGA TTC AAA GGG ATT ACT TCT ATG 
Arg Phe Lys Gly Ile Thr Ser Met 
GAC AAT TCC ATA GCT CTT GTG AAA 
Asp Ash Set  Ile Ala  Leu Val Lys 
AGT TTT GCC ATT ACA GAG GTC ACT 
Ser Phe Ala Ile Thr Glu Val Thr 
AAC ACT ATC CAC ATA ATA AAA TTA 
Ash Thr  Ile His  Ile  Ile Ly$ Leu 
TCT AAA TTT TTC ACC AAC TTC ATC 
Set Lys Phe Phe Thr Ash Phe Ile 
CAC AAT TTG CAT TCC ATG CTT TTC 
His Ash Leu His Ser Met  Leu Phe 
TCT TCG CCC TAC GTA GTT GAT GAA 
Ser Set Pro Tyr Val Val Asp Glu 
ACA TCT GTA CCT AGC GTA GAT TCC 
Thr Ser Val Pro Ser Val Asp Set 
ACT GAA GTC TTA TGT ACT GAA AGT 
Thr Glu Val  Leu Cys  Thr Glu Set 
GCA ACT TTT CGA GAA ATA GAT GAT 
Ala Thr  Phe Arg Glu  Ile Asp Asp 
AAC GTC GGG TAT CCT GCG TAC GGT GCA AAA TTT TTG AAT AAC  66 
Ash Val GIy Tyr Pro Ala Tyr GIy Ala Lys Phe Leu Ash Ash  22 
GGA GGA GAA GGA AAC AAT GGC ATA CCA AAC AAG CTG ACG GTC  132 
GIy GIy Glu GIy Ash Asn GIy Ile Pro Asn  Lys Leu Thr Val  44 
ACT GAG AAG GAA CAG TTT CAT ATA TTG AGC GAG TTT GCA TTG  198 
Thr GIu Lys Glu Gln Phe His  Ile Leu Set Glu Phe Ala Leu  66 
GCA ATT GAC GCT TCC AAG GGT ATC ATT TTG GTT GGC TGC AAT  264 
Ala Ile Asp Ala Ser Lys GIy  Ile Ile Leu Val Gly Cys Ash  88 
GGT AAA GGT AAT AAG CAC TTG AGA AAA TTT AAA TAC GAT AAA  330 
GIy Lys GIy Ash Lys His  Leu Arg Lys Phe Lys Tyr Asp Lys  Ii0 
ACT AGT GTA GAC TTT GAC GCA TCT ACA AAT GCG GAT GAC TAC  396 
Thr Ser Val Asp Phe Asp Ala Ser Thr Ash Ala Asp Asp Tyr  132 
GAA ~  GTT GCA GCT ATC GCA TCA TCT AAA GTA CCT GCT  462 
Glu GIy Thr Val Ala Ala Ile Ala Ser Set  Lys Val Pro Ala  154 
GAC TTG ACA GAG AAG TTT GAG ATC GAG ACT AGG GGT GAA GTA  528 
Asp Leu Thr Glu Lys Phe Glu  Ile Glu Thr Arg Gly Glu Val  176 
GGT AAG GTT GTT GCT TAT ATC ACC GGT TCT AGC TTG GAA GTG  594 
GIy Lys Val Val Ala Tyr  Ile Thr Gly Set Set Leu Glu Val  198 
ATT GCT AGG AAA ACA GAT TTT GAT AAG AAT TGG AGT TTA TCT  660 
Ile Ala Arg Lys Thr Asp Phe Asp Lys A~n Trp Ser Leu Ser  220 
ACA GTA TTG ATA GCA GCC TCT TTA AAA AAA GGG AAA GGT ATT  726 
Thr Val Leu  Ile Ala Ala Ser Leu Lys  Lys Gly Lys Gly Ile  242 
TCA GGA AAC ACT TCC GTA TTA AGA TCC AAA CAA GTG ACA AAC  792 
Ser GIy Asn Thr Set Val Leu Arg Set Lys Gln Val Thr Ash  264 
SalI• 
GAT ~'-~  ATG AAG GGT GAA TTG GCG GTA CTG GCA AGT AAT  858 
Asp Val Asp Met  Lys Gly Glu  Leu Ala Val Leu Ala Ser Ash  286 
CTA AAA GAC CTG TCA ATG TCT AAA ATA TTC AAA CAA GCT CAT  924 
Leu Lys Asp Leu Se/ Met Set  Lys  Ile Phe Lys Gln Ala His  308 
ATC TCT CCG GAC TCT ACA TAT GTG GCG AGT GTT TCG GCA GCC  990 
Ile Set Pro Asp Set Thr Tyr Val Ala Set Val Ser Ala Ala  330 
CCG CTT AAC TAC GCC AAC TAC ACC TCA ATG AAA CAA AAA ATC 1056 
Pro Leu Asn Tyr Ala Asn Tyr Thr Set Met  Lys Gln Lys  Ile  352 
CTT ATT GTG CTG CTT TCT TAC ATT TTA CAG TTC TCC TAT AAG 1122 
Leu Ile Val Leu  Le~ Set Tvr  Ile Leu Gln Phe Set Tvr Lys  374 
AAT TAC GCG AAG GAC AAT TTT CTA ACG AAA AGA GAC ACC ATC 1188 
Ash Tyr Ala Lys Asp ASh Phe  Leu Thr  Lys Arg Asp Thr  Ile  396 
GAC TTA CAT CAA ACA ACT TTG TTT GGC AAC CAC GGT ACA AAA 1254 
Asp Leu His Gln Thr Thr  Leu Phe GIy Asn His GIy Thr  Lys  418 
ATA AAA GTG CAT GGC GTG CAT GAG ACG AGT TCT GTG AAT GGA 1320 
Ile Lys Val  His Gly Val  His Glu Thr Set Set Val Ash Gly  440 
AAC ATT ATT AAT ACT GGA GGG GCA GAG TTT GAG ATC ACC AAC ]386 
Ash  Ile  Ile Ash Thr Gly Gly Ala Glu  Phe Glu  lie Thr Ash  462 
GCT TGA GCT TGA GAGAAAGTTATGAGGTAGCAATAATGAAGTAGCGAAAAG 1461 
Ala  *  *  471 
1548 
1553 
GAGAGTGACGACACTCAAGCTATGAAAAAAAACGCAAAGATACAAAAACGATCTCAATGATATTGATGATAGAGATTTATCTGATAA 
ATTAG 
Figure 2. Nucleotide sequence of SEC12 gene and its predicted amino acid sequence.  Solid triangles  indicate possible sites of N-gtycosyla- 
tion.  Underline  indicates  a hydrophobic  stretch of 19 amino acid residues. 
tion.  pSEC1210  suppressed  three  separate  ts  isolates  of 
sec12(sec12-1,  -3, and -4),  but did not suppress the effect of 
a disrupted SEC12 gene (see below).  Hence,  the suppressor 
function  on this  DNA  clone  must  work in  concert  with  a 
partly defective Secl2 protein, and not in the absence of the 
protein. The nature of the suppressor gene is currently being 
investigated. 
As with all other yeast sec mutants, sec12 was isolated as 
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Poly(A)  + RNA from wild-type yeast was resolved on an agarose 
gel and blotted to nitrocellulose. Nick-translated DNA probes con- 
taining the internal fragment of SEC12 (lane 1 ) and whole SEC12 
and URA3  genes (lane 2) were used for hybridization. 1. 7kb, SECI2 
message; 0.9 kb, URA3 message. 
charged).  Hydropathic analysis by the method of Kyte and 
Doolittle (22) detected a  hydrophobic stretch of 19 amino 
acids (Fig. 2, underline) flanked by three positively charged 
amino acids on both sides.  This is a  feature typical of the 
membrane-spanning  domains  of  integral  membrane  pro- 
teins. Other hydrophobic sequences predicted in SEC12 were 
not of sufficient length to  span  a  membrane lipid bilayer. 
Seven triangles  in  Fig.  2  depict possible  N-glycosylation 
sites.  The protein is  rich in serine and threonine residues 
which are possible acceptors of O-linked oligosaccharides 
(see  below).  No  significant homology in  amino  acid  se- 
quence was found to proteins catalogued in the protein data 
bank from the National Biomedical Research Foundation (23). 
Transcription of SEC12 was examined by Northern hybrid- 
ization. The DNA fragment internal to SEC12 (Fig.  1, frag- 
ment D) was used as a probe to identify SEC12 mRNA. As 
shown in Fig. 3, lane 1, a single species of ~1.7 kb was seen, 
which corresponded to the size of SEC12 message predicted 
from the DNA sequence. To estimate the abundance of this 
mRNA, the hybridization intensity was compared to URA3 
mRNA  (0.9  kb)  using  a  nick-translated  probe containing 
both the SEC12 and URA3 genes (YIp5 containing fragment 
B of Fig. 1). Lane 2 in Fig. 3 shows that the probe hybridized 
SEC12 mRNA about half as strongly as URA3 mRNA. As- 
suming that the URA3 message represented ~0.1% of total 
mRNA (1), a simple calculation leads to an estimate that the 
SEC12 message was ,~0.02-0.03 % of total mRNA or two to 
four copies per cell.  A  similar  Northern blot experiment 
using single-stranded DNA probes confirmed the direction 
of transcription as shown in Fig.  1 (data not shown). 
a conditional ts lethal, supporting the assumption that pro- 
tein secretion is coupled to cell surface expansion and there- 
fore to cell growth (28). To test the possibility that sec12 iso- 
lates  were  null  mutations  that  exposed  an  independent 
thermosensitive process,  the chromosomal copy of SEC12 
was disrupted and the phenotypic consequences monitored. 
The internal Bam HI-Sal I fragment of the SEC12 gene (Fig. 
1, fragment D) was subcloned into YIp5, linearized by cleav- 
age with Kpn I, and introduced into a SEC12/SEC12, ura3/ 
ura3 diploid strain,  TAY69. Stable transformants were in- 
duced to sporulate and the resulting tetrads dissected. Among 
33 asci analyzed, 24 gave rise to two viable spores and 9 
tetrads produced only one progeny. None of the viable spores 
were Ura  +. A Southern hybridization experiment confirmed 
that the diploid transformants contained both the wild-type 
and disrupted copies of SEC12, whereas all viable progeny 
contained only the wild-type copy (data not shown). These 
observations indicated that spores with the disrupted SEC12 
gene could not initiate cell division. Hence SEC12 is directly 
essential for cell growth. 
DNA Sequence and Transcription of SECI2 
The nucleotide sequence of a 1.7-kb DNA fragment contain- 
ing the SEC12 gene was determined.  As  shown in Fig.  2, 
SECI2 contained a single long open reading frame uninter- 
rupted with introns, preceded by several stretches of A's and 
a TATA sequence (Fig. 2, box), and terminated by two TGA 
codons. A polypeptide of 471 amino acids is predicted with 
an  amino  acid  composition  of high  hydrophilicity  (25% 
Identification of the SEC12 Gene Product, Secl2p 
To identify and characterize the SEC12 gene product, Secl2p, 
we prepared an antibody against a lacZ-SEC12 fusion gene 
product. The fusion (Fig. 4 a) contained the promoter region 
and almost the whole coding sequence of the E.  coli lacZ 
gene, contained on the fusion vector pUR290 (32), joined to 
90% of the SEC12 coding sequence at the Bam HI site.  E. 
coli  strain  BMH71-18  transformed  with  this  gene  fusion 
(pANF1)  produced a  novel 160-kD protein upon induction 
with isopropylthio-[3-D-galactoside. This hybrid protein was 
purified and used to immunize rabbits.  The resulting poly- 
clonal antiserum showed titer against both E.  coli [3-galac- 
tosidase and yeast Secl2p epitopes, and was  used without 
further purification. 
Secl2p was  detected  in  yeast extracts by two methods. 
First,  wild-type or sec12 yeast cells that contained a  mul- 
ticopy plasmid with or without the SEC12 gene insert were 
lysed and analyzed by SDS-PAGE and Western immunoblot- 
ting (Fig. 4 b). The antibody recognized a single band with 
an apparent molecular mass of 70 kD when the SEC12 plas- 
mid was present in the cells (Fig. 4 b, lanes 2 and 4). This 
band was not readily detected in the absence of the multicopy 
SECI2 gene (Fig. 4 b, lanes I and 3), indicating that Secl2p 
was  not abundant.  The mutant sec12 strain  harboring the 
SEC12 multicopy plasmid (Fig. 4 b, lane 4) had a higher level 
of Secl2p expression than the wild-type strain containing the 
same plasmid (Fig. 4 b, lane 2), though both transformants 
grew similarly at 37°C. 
Secl2p was also detected by immune precipitation from 
extracts  of radiolabeled  cells.  The  wild-type  strain  over- 
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Secl2p. (a) A construct oflacZ-SEC12 gene fusion 
used for raising anti-Secl2p antibody. The hybrid 
protein was produced in E. coli, purified, and in- 
jected into rabbits to yield a polyclonal antiserum. 
(b) Western blot analysis of  yeast extracts using the 
obtained  anti-Secl2p  antibody. The  wild-type 
(SEC  +, ANY1-7D) and mutant (sec12, MBYI0-7A) 
strains  with  a multicopy plasmid  containing the 
SEC12 gene  (+,  pANY1-9) or vector alone  (-, 
pSEY8) were grown in a minimal medium lacking 
uracil to maintain the plasmid. Extracts were pre- 
pared by agitation with glass beads in the SDS gel 
sampling buffer. Proteins were resolved on a poly- 
acrylamide gel and blotted to a nitrocellulose filter. 
The filter  was decorated  with  anti-Secl2p anti- 
body  and  [t25I]protein A,  and  exposed  to  x-ray 
film. Arrowhead, Secl2p (70 kD).  (c) Immuno- 
precipitation of Secl 2p. A wild-type strain harbor- 
ing  the  SEC12 multicopy  plasmid  (ANYI-7D/ 
pANY1-9) was labeled  with  [358]sulfate at 30°C 
for 1 h and an extract prepared by agitation with 
glass beads in the presence of 1% SDS. The extract 
was adjusted to 1.6% Triton X-100, 0.2% SDS, and 
subjected to immunoprecipitation  using a preim- 
mune serum or the immune anti-Secl 2p antiserum 
in  combination  with  protein  A-Sepharose.  The 
immunoprecipitates were resolved on an SDS gel 
and fluorographed.  Arrowhead, Secl2p. 
producing  Secl2p was grown  in  minimal  medium and  la- 
beled with [35S]SO42- at 30°C for 1 h.  Extracts treated with 
anti-Secl2p antibody and Protein A-Sepharose precipitated 
a single species (Fig. 4 c). This protein was not precipitated 
by preimmune serum (Fig. 4 c, lane 5) or when the immune 
serum incubation was performed in the presence of excess 
purified lacZ-SEC12  hybrid protein (data not shown). 
Secl2p, a Membrane Protein That Fractionates with 
Rapidly Sedimenting Membranes 
Secl2p was examined in subcellular fractions obtained from 
a  wild-type strain harboring the SEC12 multicopy plasmid. 
Cells were converted to spheroplasts, homogenized, and sub- 
jected to differential centrifugation.  All fractions were ana- 
lyzed by Western immunoblotting. The data in Fig. 5 a show 
that Secl2p was almost exclusively found in a LSP fraction. 
Only a small amount was detected in LSS or HSP fractions; 
nothing remained soluble after a high speed centrifugation. 
Table II shows the distribution of various marker proteins in 
these fractions.  A  cytosolic protein (cytoplasmic invertase) 
was recovered in the HSS. Vacuolar proteins were found pre- 
dominantly in the LSP.  However, 40 % of a  soluble protein 
(mature CPY) was recovered in  the HSS and a  significant 
amount of a vacuolar membrane protein (heat-labile DPAP) 
was detected in the HSP. A Golgi enzyme, heat-stable DPAP, 
fractionated equally in the LSP and HSP. The bulk of the ER 
marker enzyme, NADPH cytochrome c  reductase,  was re- 
covered in the LSP.  Hence, the Secl2p was contained in a 
mixed membrane fraction that included most of the  ER. 
Two experiments were conducted to test whether Secl2p 
was soluble in a membrane-enclosed compartment or was an 
integral  membrane  protein.  First,  the  LSP  fraction  was 
treated with 0.1  M  Na2CO3,  pH 11.5, and centrifuged. This 
treatment generated membrane sheets, removing soluble and 
peripherally  associated  membrane proteins  (15).  Fig.  5  b 
shows  that  Secl2p  remained  sedimentable after this treat- 
ment,  suggesting a  firm association with the  lipid bilayer. 
Second, a "detergent blotting" method developed by Ito and 
Akiyama (19)  was used to assess membrane association of 
Secl2p. In a modification of the normal immunoblot proce- 
dure, this technique uses a polyacrylamide gel containing the 
detergent NP-40 inserted between the original SDS gel and 
a nylon membrane. During electrophoretic transfer from the 
SDS  gel to  nylon,  integral  membrane proteins  form large 
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ization by biochemical analyses. (a) Sub- 
cellular  fractionation  of  membranes. 
Wild-type  cells  containing  the  SEC12 
multicopy plasmid (ANYI-7D/pANYI-9) 
were converted  to spheroplasts  and ho- 
mogenized.  The  homogenate  (2.9  mg 
protein/ml)  in 0.3  M  mannitol,  0.1  M 
KCI, 50 mM Tris-HCl, pH 7.4,  1 mM 
EGTA was centrifuged at 1,000 g for 10 
min to separate LSP from LSS fractions. 
LSS  was  further  fractionated  by  cen- 
trifugation at 100,000 g for 1 h into HSP 
and  HSS  fractions.  Each  fraction 
equivalent  to  10D60o of cells  was  re- 
solved on an SDS gel and subjected  to 
immunoblot analysis  using anti-Secl2p 
antibody.  Arrowhead, Secl2p.  (b)  So- 
dium carbonate treatment  of LSP. The 
LSP fraction at a final protein concentra- 
tion of 10 mg/ml was treated with 0.1 M 
NazCO3, pH 11.5, on ice for 30 min and 
centrifuged at 100,000 g for 1 h. Super- 
natant (sup) and pellet (ppt) fractions de- 
rived  from  the  same  amount  of LSP 
were analyzed by immunoblot to deter- 
mine the distribution  of Secl2p. Arrow- 
head, Secl2p. (c) "Detergent  blot" anal- 
ysis of Sect 2p. The same wild-type cells 
(ANY1-7D/pANYI-9) were labeled with 
[355]SO42- at 30°C for 1 h, lysed by agi- 
tation with glass beads  in the presence of 1% SDS, and subjected to immunoprecipitation  with anti-Secl2p (lanes 8 and 10) or anti-CPY 
(lanes 9 and H ) antibodies.  Immunoprecipitates were resolved on an SDS-polyacrylamide gel and electrophoretically  transferred  to a nylon 
membrane. In this  transfer,  another polyacrylamide gel containing  1% NP-40 was placed  between  the original  SDS gel and nylon (19). 
After transfer, the NP-40 gel and nylon were dried and autoradiographed.  Arrowhead, Secl2p; open triangle, CPY. Other prominent bands 
are contaminants  in the immunoprecipitates. 
micelles with NP-40 molecules and are markedly retarded in 
migration.  Secl2p,  as  well  as the  soluble  vacuolar protein 
CPY as a control, were immunoprecipitated from wild-type 
cells  labeled  with  [35S]SO42- and  subjected  to  detergent 
blotting. Fig. 5 c shows that Secl2p was trapped in the NP-40 
gel (Fig. 5 c, lane 8), whereas CPY passed through and was 
blotted to nylon (Fig.  5  c,  lane//).  These results  substan- 
tiated  the  prediction  that  Secl2p  is  an  integral  membrane 
protein. 
The orientation of Secl2p with respect to the bilayer was 
probed by treatment of homogenates with trypsin in the pres- 
Table II. Subcellular Fractionation of Wild-Type Yeast 
%  Total 
Protein  Localization  LSP  HSP  HSS 
Total protein  26  23  51 
Invertase*  Cytosol  3  3  94 
Mature CPY*  Vacuole content  50  10  40 
Heat-labile DPAP  Vacuole membrane  65  24  11 
Heat-stable DPAP  Golgi membrane  45  46  9 
Cytochrome c reductase  ER membrane  76  14  10 
Sec 12p*  90  9  < 1 
The same fractions as in Fig. 5 a  were analyzed. Proteins were quantified by 
Western blotting (*) or their activities were determined. 
ence or absence of Triton X-100. Without detergent,  Secl2p 
was not degraded during 30 rain at 0°C (Fig. 6 a, lanes 1-4). 
When the detergent was present,  Secl2p was degraded rap- 
idly to produce a 43-kD fragment (Fig. 6 a, lanes 5-8). No 
shift in the mobility of Secl2p was produced in incubations 
that contained detergent  but no protease  (Fig.  6  a,  lanes  9 
and 10). Resistance to trypsin in the absence of the detergent. 
was not seen for cytosolic proteins (data not shown). These 
observations indicate that some site(s) in Secl2p was accessi- 
ble to trypsin only when the membrane was permeabilized. 
Similar  experiments  using  proteinase  K  instead  of trypsin 
and  saponin  instead  of Triton X-100 gave the  same  results 
(data  not shown). 
The  presence  or  absence  of N-linked  carbohydrate  on 
Secl2p and on the 43-kD fragment was used to probe further 
the orientation of Secl 2p with respect to the membrane. Five 
potential  N-glycosylation  sites  are  found  in  the  NH2-ter- 
minal hydrophilic domain that precedes  the putative mem- 
brane anchor peptide (Fig. 2); two such sites are represented 
on  the  COOH-terminal  domain.  If the  NH2-terminal  do- 
main faces the lumen of the organelle in which Secl2p re- 
sides,  and proteolysis in the presence of detergent removes 
this  domain  from the  whole protein,  the  43-kD  fragment 
should  be  glycosylated.  If  the  43-kD  fragment  instead 
represents a cytoplasmic, protease-resistant domain attached 
to the membrane anchor, with a trypsin cleavage site in the 
lumenal COOH-terminal domain, then the 43-kD fragment 
Nakano et al, Secl2p in ER-to-Golgi Transport  857 Figure 6. Susceptibility of Secl2p to tryptic digestion from the cytoplasmic side of the membranes.  (a) The homogenate from wild-type 
cells (ANY1-7D/pANYI-9), identical to that shown in Fig. 5 a, lane 1, was treated on ice with (lanes 1-8) or without (lanes 9 and 10) 
0.5 mg/ml trypsin in the absence (lanes 1-4) or presence (lanes 5-10) of 0.1% Triton-X-100. After the indicated times, tryptic action was 
stopped by the addition of 1A  mg/ml soybean trypsin inhibitor. Each sample equivalent to 10D60o of cells was resolved on an SDS gel 
and subjected to immunoblotting with anti-Secl2p antibody. Arrowheads,  mature 70-kD form and 43-kD fragment of Secl2p.  (b) Endo 
H sensitivity of the 70-kD protein and 43-kD fragment was examined. A homogenate was treated with 0.5 mg/ml trypsin in the presence 
of 0.1% Triton X-100 on ice for 0 or 30 min.  Digestion was stopped by the addition of trypsin  inhibitor followed by heating to 95°C in 
the presence of 1% SDS. Samples were divided in half, brought to final concentrations of 0.3% SDS, 0.15 M sodium citrate, pH 5.5, and 
5 mM NAN3, and treated with or without 0.05 U/ml endo H at 37°C for 18 h. Secl2p polypeptides were resolved on an SDS gel and de- 
tected by immunoblotting with anti-Secl2p antibody. 
will not be glycosylated. Samples from untreated or trypsin 
+  Triton X-100-treated fractions were exposed to endo H. 
The data in Fig. 6 b shows that heterogeneous 70-kD Sec 12p 
was converted to a more defined 65-kD species by removal 
of N-linked carbohydrate. In contrast, the 43-kD proteolytic 
fragment migrated sharply and was not reduced in apparent 
molecular mass by endo H treatment. This result suggested 
that the 43-kD fragment was not glycosylated and may repre- 
sent a cytoplasmically oriented, protease-resistant domain of 
Secl2p. 
Progressive Glycosylation of  Sec12p 
The 70-kD form of Secl2p detected by immunoblotting was 
larger than expected from the DNA sequence (Fig. 2; 51.6- 
kD polypeptide predicted).  At least part of this difference 
was due to N-linked carbohydrate (Fig. 6 b). To detect addi- 
tional covalent modifications of the polypeptide that would 
account for this discrepancy, the biosynthesis of Secl2p was 
examined in a pulse-chase experiment. Wild-type cells were 
pulse labeled with [35S]SO42- for 5 min and chased for the 
indicated times in the presence (Fig. 7, lanes 1-5) or absence 
(Fig.  7,  lanes 6-10) of tunicamycin.  In the control,  newly 
synthesized Secl2p displayed a gradual increase in apparent 
molecular mass up to 70 kD during the chase (Fig. 7, lanes 
6-10). In the presence of tunicamycin, Secl2p increased in 
size over a lower range of molecular mass (Fig. 7, lanes 1-5). 
The apparent size difference was "-,5 kD at each time point. 
Endo  H  treatment  of  Secl2p  labeled  in  the  absence  of 
tunicamycin gave the same decrement of 5  kD in apparent 
molecular mass (Fig.  6  b).  This result suggested that only 
part of the size anomaly of Secl2p was due to N-glycosyla- 
tion with one or two oligosaccharide chains. 
The progressive decrease in  electrophoretic  mobility of 
Secl2p was not due to modification of N-linked sugars be- 
cause it occurred in the presence or absence of tunicamycin. 
To test the possibility that some other glycosyl modification 
took place, binding of Secl2p to concanavalin A (Con A) was 
examined (Fig.  8); and samples from a pulse-chase experi- 
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modification of Secl2p. Wild- 
type cells (ANY1-7D/pANYI- 
9) were grown in a low sulfate 
medium, washed,  and resus- 
pended  in  minimal medium 
with no sulfate.  Three tubes, 
each containing 20D60o cells 
in 1 ml medium, were prein- 
cubated  at 30°C for  15  min. 
Cells were then pulse labeled 
with 2 mCi [35S]SO42- at 30°C 
for 5 min, and chased by the 
addition of cold sulfate,  cys- 
teine,  and  methionine.  The 
first tube (lanes 1-5) contained 
10  txg/ml tunicamycin from 
the  period  of  preincubation 
through the chase, the second 
tube contained no drugs (Con- 
trol, lanes 6--10), and the third 
tube received 100 lag/ml cyclo- 
heximide  at the beginning of 
the chase period (lanes 11-15). 
After chase  at  30°C  for  the 
times  indicated,  180-1al ali- 
quots  were  withdrawn  from 
each tube.  Extracts  were pre- 
pared by agitation  with glass 
beads in the  presence of 1% 
SDS, and Sec 12p was immu- 
noprecipitated. 
Figure  8.  Con  A  binding of  Secl2p. 
Wild-type  cells  (ANYI-7D/pANY1-9) 
were  pulse  labeled  and chased  in the 
presence  or  absence  of  tunicamycin 
(TM) as described in the legend to Fig. 
7. Extracts were prepared  from samples 
taken at the indicated chase times and in- 
cubated with Con A-Sepharose CL-4B 
in 1.6% Triton X-100, 0.1% SDS, 0.5 M 
NaC1, and 20  mM sodium phosphate, 
pH 7.4. To ensure quantitative binding  of 
glycoproteins,  5  gtl of swollen Con A- 
Sepharose beads were used for extracts 
equivalent to 0.10D60o of cells.  After 
gentle agitation at room temperature  for 
3 h, beads were collected by a brief spin 
in a microfuge and the supernatant frac- 
tion containing unbound material  was 
saved.  Beads  were washed  three  times 
with 0.05% SDS, 0.5 M NaCI,  and 20 
mM Tris HC1, pH 7.4, and treated with 
1%  SDS in a boiling water  bath for 5 
min.  Eluted  material  was  adjusted  to 
1.6% Triton X-100 and 0.2%  SDS  in 
PBS and subjected to immunoprecipita- 
tion with anti-Secl2p or anti-CPY anti- 
body.  Immunoprecipitation  was  also 
performed for total extracts and unbound 
fractions  in parallel.  T, total extract;  B, 
bound  fraction;  U,  unbound fraction. 
Two major bands in lanes 13-15 derive 
from  precursor  and  mature  forms  of 
CPY (40). 
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secl&  A  sec18 strain  harboring  the  SEC12 multicopy  plasmid 
(MBY12-6D/pANYI-9) as  well as  the  wild-type  strain  (SEC  +, 
ANY1-7D/pANYI-9) were suspended in minimal medium contain- 
ing no sulfate. After preincubation for 15 min at 30°C, cells (6 
OD60o)  were labeled with 6 mCi [35S]SO42- for 5 rain and chased 
at 30°C. After t0 min,  1 h, and 3 h of chase, 20D6~ cells were 
withdrawn and mixed with an equal volume of 20 mM NaN3 on 
ice. SDS extracts were prepared and Secl2p immunoprecipitated. 
Arrowhead, Secl 2p. 
ment were incubated with Con A-Sepharose beads.  After 
3 h at room temperature, samples were centrifuged and the 
supernatant fraction was removed. The bound material was 
eluted in an SDS solution. Secl2p and CPY were immuno- 
precipitated from total  (T),  bound  (B),  and  unbound (U) 
fractions. As shown in Fig. 8, lanes 4-12,  Secl2p, made in 
the  absence  (-TM)  or  presence  (+TM)  of tunicamycin, 
bound to Con A-Sepharose. On the other hand, CPY, which 
is known to have only N-linked oligosaccharides, bound to 
Con  A-Sepharose  when  synthesized  in  the  absence  of 
tunicamycin (Fig.  8, lanes 1-3), but did not when made in 
the presence of the drug (Fig.  8, lanes 13-15).  The binding 
of Secl2p to Con A was due to sugar-lectin interaction be- 
cause  0.5  M  a-methyI-D-mannoside  completely  released 
Secl2p from the beads (data not shown). Thus, we conclude 
that Secl2p undergoes two different types of glycosylation: 
one  N-linked  and  the  other  of unknown  character.  Both 
glycosylation reactions were detected on newly synthesized 
Secl2p (even in the 10-min chase; see Fig. 8, lanes 7-9), al- 
though the gradual decrease in electrophoretic mobility re- 
quired as long as 3 h for completion (Fig. 7). This processing 
was extremely slow compared to the time required for glyco- 
sylation of a typical secretory protein such as invertase (30). 
A  role for ongoing protein synthesis  in the posttransla- 
tional  modification  of Secl2p  was  examined  with  pulse- 
labeled cells chased in the presence of cycloheximide. The 
data in Fig. 7, lanes 11-15, show that when cells were treated 
with cycioheximide the electrophoretic mobility of Secl2p 
did not decrease and become as heterogeneous as in the con- 
trol. Secl2p matured in the presence of cycloheximide had 
the same mobility as the form produced during a  l-h chase 
in the control sample. Therefore, early processing of Secl2p 
occurred  normally  in  the  absence  of  protein  synthesis 
whereas later events were blocked. 
Sec12p in the Golgi Apparatus 
The extensive modification of Secl2p resembled the kind of 
heterogeneous glycosylation that accompanies transport of 
secretory molecules through the Golgi apparatus (12).  This 
possibility was tested with another sec mutant strain, secl8, 
in which protein transport from the ER is defective, sec18 
(31) and  wild-type strains  harboring the SEC12 multicopy 
plasmid were labeled with [35S]SO42- for 5 min at 30°C (a 
restrictive temperature  for sec18-1), followed  by  a  chase 
period of 10 min,  1 h, or 3 h at 30°C.  In the earliest time 
point,  Secl2p  immunoprecipitated from extracts of wild- 
type or mutant cells migrated at the 65-kD position seen ear- 
lier (compare Fig. 7, lane 7with Fig. 9, lanes 1 and 2). After 
1 h of continued incubation at 30°C, and more dramatically 
after 3 h, Secl2p in the wild-type strain was converted to a 
species of heterogeneous migration, while that produced in 
the secl8 strain persisted at the same position of migration 
(Fig. 9, lanes 3-4). In addition, Secl2p accumulated in secl8 
appeared to be labile, perhaps a result of degradation as a 
consequence of a  failure to mature or localize the protein 
properly. From this we suggest that the early processing of 
Secl2p seen in Fig. 7, lanes 6-8, occurred in the ER, while 
the later modification (Fig. 7, lanes 9 and I0) required trans- 
port to the Golgi apparatus. 
Immunoelectron microscopy using a protein A-gold method 
was  used to localize Secl2p in thin sections.  As shown in 
Fig. 10, a and c, Secl2p was observed in the Golgi apparatus 
when this organelle was accumulated in a sec7 strain (Golgi- 
accumulating mutant) that was overproducing Secl2p. Gold 
particles were not observed beyond a background level when 
the labeling was competed with lacZ-SEC12  hybrid protein 
(Fig. 10, b and d) or when Secl2p was not overproduced (not 
shown). This result supported a role for the Goigi apparatus 
in Secl2p biogenesis. Unfortunately, Secl2p was not repro- 
ducibly visualized in wild-type or secl8 cells, even with cells 
that contained the multicopy SEC12 plasmid.  Detection by 
this method may require a high local concentration of the an- 
tigen. Secl2p may be diluted over the large luminal surface 
of the ER, or the protein may be masked by close interaction 
with other components in this organelle. 
Discussion 
Molecular cloning and sequence analysis of the SEC12 gene 
predicts a protein with a single potential membrane-spanning 
domain. Antibody generated against the SEC12 product de- 
tects a membrane glycoprotein in yeast that resides in an in- 
tracellular compartment. This glycoprotein, Secl2p, is over- 
produced when yeast cells are  transformed with a  SEC12 
multicopy plasmid,  and  immune precipitation of the yeast 
protein is  competed by excess SEC12 product made  in E. 
coli. 
Routine  immune detection of Secl2p has  been possible 
only in lysates of cells that harbor the SEC12 gene on a mul- 
ticopy plasmid,  therefbre it appears that Secl2p is  not an 
abundant protein in normal cells. Although our conclusions 
concerning Secl2p localization, or the rate of its maturation, 
may be influenced by the requirement for detecting an over- 
produced protein, the apparent size of Secl2p does not de- 
pend on SEC12 gene dosage. Prolonged autoradiography of 
SDS  gels  containing  normal  and  overproduced  levels  of 
Secl2p show the same ~70-kD species. 
Secl2p resides in a rapidly sedimentable intracellular com- 
partment(s),  possibly the ER.  Proteolysis of homogenates 
shows  that  Secl2p  has  a  site(s)  susceptible  to  proteases 
within a membrane-enclosed compartment. This observation 
The Journal  of Cell Biology, Volume 107, 1988  860 Figure I0. Electron microscopic localization of Secl2p in a Golgi-accumulating mutant, secZ A sect strain harboring the SECI2 multicopy 
plasmid (SF821-8A/pANY1-9) was fixed and embedded in Lowicryl K4M. (a and c) Thin sections were incubated with anti-Secl2p antibody 
followed by protein A-gold (8-nm particles).  (b and d) The same incubation as in a was performed in the presence of purified lacZ-SEC12 
hybrid protein.  Bars,  1 Inn. 
diminishes the possibility that Secl2p resides in the plasma 
membrane which in homogenates of yeast spheroplasts re- 
mains in open sheets with both cytoplasmic and extracellu- 
lar surfaces exposed (7,  39).  Two possible orientations of 
Secl2p within an organelle membrane are shown in Fig.  11. 
I 
a  b 
C 
lumen  ~jll~ ~. 
CHO  --'~~  (~ 
Figure 11. Models of Secl 2p structure in a membrane. N and C indi- 
cate amino and carboxyl termini of Secl2p,  respectively. Arrows, 
putative  sites  susceptible  to  tryptic  digestion;  CHO,  N-linked 
carbohydrates. 
Both models seek to account for the production  of a  non- 
glycosylated  43-kD  fragment  of  Secl2p  produced  when 
membranes are treated with trypsin in the presence of deter- 
gent. Model a  suggests the COOH-terminal domain, which 
from the sequence data contains two potential N-glycosyla- 
tion sites, occupies a lumenal position.  A  potential trypsin 
cleavage site is  located on the COOH-terminal side of the 
putative membrane-spanning domain. Proteolysis at this po- 
sition would,  in the absence of cleavage at any more NH2  o 
terminal site,  generate a  374-amino acid-long polypeptide 
('~41 kD). Model b places the NH2-terminal domain in the 
lumen with one glycosylation site separating the membrane 
anchor from the  trypsin cleavage site.  A  337-amino acid- 
long ('~37 kD) possible proteolytic fragment is the largest 
NH2-terminal  segment  that  conforms  to  this  model.  Fur- 
thermore, for model b to be correct, the four other potential 
N-glycosylation sites in the NH2-terminal domain of secl2p 
must  somehow  escape  recognition  by the  oligosaccharide 
transfer apparatus. For these reasons we favor model a  and 
suggest  that  the  protease  resistance  of the  exposed  NH2- 
terminal domain may derive from unusual folding or through 
interaction with other proteins. In any case, this domain may 
provide an anchoring site for cytoplasmic proteins involved 
in membrane sorting or vesicle budding, 
Glycosylation of Secl2p proceeds in an unusual  manner 
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oligosaccharides. Of the ,x,18-kD apparent molecular mass 
difference between the polypeptide predicted from the DNA 
sequence and the protein detected on immunoblots, ,'~5 kD 
is due to N-glycosylation. An additional glycosyl modifica- 
tion independent of N-linked oligosaccharides occurs during 
or shortly after synthesis of Secl2p. This species, labeled in 
the presence of tunicamycin, binds Con A and is eluted by 
ct-o-methylmannoside.  Among the possibilities  for this modi- 
fication are O-linked mannose, whose assembly on yeast 
glycoproteins begins in the ER (16), or a mannose-contain- 
ing glycolipid anchor (24), a structure that has not yet been 
examined in yeast. 
Yet another modification of Secl2p, accounting for ~4 kD 
of apparent  molecular mass,  occurs  slowly and  depends 
upon transit to the Golgi apparatus. This component is inde- 
pendent of N-linked glycosylation and may represent matu- 
ration of the other carbohydrate structure, or an altogether 
new modification. Although protein transport through the 
yeast secretory pathway ordinarily is rapid and does not re- 
quire ongoing protein synthesis (30, 31), the slow modifica- 
tion of Secl 2p is blocked by cycloheximide. One speculative 
interpretation of this result is that Secl 2p migrates rapidly in 
a  cycle from the ER to the Golgi apparatus and back, ex- 
periencing progressive modification in successive passages 
through the Golgi apparatus. Transport of Secl2p from the 
ER may require a cargo of newly made proteins such that in- 
hibition of protein synthesis retards its cycling.  A precedent 
for ligand-dependent cycling is seen in epidermal growth fac- 
tor-stimulated internalization of the epidermal growth factor 
receptor in liver (10). Alternatively, the enzymes that slowly 
modify Secl2p may be turned over rapidly, resulting in a 
depletion of activity during prolonged inhibition of protein 
synthesis. Since protein transport from the ER to the Golgi 
apparatus is interrupted in Sec12 cells, these results and the 
immune EM visualization of Secl2p in Golgi structures sug- 
gest that this protein may serve both in protein transport from 
the ER and within the Golgi apparatus. 
One possibility for the function of Secl2p is in packaging 
the precursors of secretory, plasma membrane, and vacuolar 
proteins into the vesicular intermediates that mediate com- 
partmental traffic within the cell. Accordingly, Secl2p should 
be enriched in these vesicles. Thus far, the only such vesicle 
that has been identified in yeast is the mature secretory vesi- 
cle involved in transport from the Golgi apparatus to the 
plasma membrane (28),  which does not appear to contain 
Secl2p (Holcomb, C., and A. Nakano, unpublished results). 
Hence, either Secl 2p plays no role in the formation of secre- 
tory vesicles derived from the Golgi apparatus, or it does so 
without being packaged into the membrane of this vesicle. 
In the course of cloning the SEC12 gene, a suppressor gene 
was obtained which, when its dosage is raised, allows sec12 
ts mutant cells to grow at 37°C. Deletion of the chromosomal 
locus of the suppressor gene in a wild-type cell is a lethal 
event, hence the suppressor product is essential for normal 
growth. Interestingly, the sequence of this gene predicts a 
ras-related GTP-binding protein (Nakano, A., manuscript in 
preparation).  A  similar finding has been reported for the 
SEC4 gene,  which encodes a  distinct ras-homologue  and 
which partially suppresses the ts growth phenotype of several 
mutants that accumulate secretory vesicles at 37°C  (33). 
From these results,  it appears  that different GTP-binding 
proteins may regulate each stage in the secretory pathway. A 
further test of this hypothesis requires  the generation  and 
analysis of conditional alleles of the SEC12 suppressor gene. 
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